Viewing Study NCT01901133


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-06 @ 2:22 PM
Study NCT ID: NCT01901133
Status: COMPLETED
Last Update Posted: 2014-09-15
First Post: 2013-06-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group
Sponsor: Astellas Pharma Europe B.V.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pharmacokinetics of MDV3100 View
None Healthy Subjects View
None Kidney Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 1 View
None MDV3100 View
None Hepatic Impairment View
None Kidney Diseases View
None Xtandi View
None enzalutamide View